[시장보고서]멀티오믹스 시장 : 규모, 점유율, 동향 분석, 제품 및 서비스별, 유형별, 플랫폼별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

멀티오믹스 시장 : 규모, 점유율, 동향 분석, 제품 및 서비스별, 유형별, 플랫폼별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1771643

리서치사 : Grand View Research

발행일 : 2025년 06월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,605,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,051,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,944,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

멀티오믹스 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 멀티오믹스 시장 규모는 2033년까지 98억 1,000만 달러에 이르고, 2025년부터 2033년까지의 CAGR은 15.33%를 나타낼 전망입니다.

오믹스 기술의 비용저하, 민간 및 공적기업으로부터의 투자 및 자금조달 증가 등의 요인이 시장을 견인할 것으로 예측됩니다.

기술 향상으로 인해 오믹스 기술의 비용이 줄어들고 연구자들이 데이터세트에 쉽게 액세스할 수 있을 것으로 예측됩니다. 바이오인포매틱스를 고려한 스토리지 옵션을 이용하여 원시 시퀀싱 데이터를 보존하고 비용을 절감할 수 있습니다.

민간 및 공공 참가자들의 투자와 자금 제공 증가는 멀티오믹스 제품 및 서비스에 대한 수요를 끌어올릴 것으로 예측됩니다. Roche는 생명공학 기업인 Freeome에 2억 9,000만 달러를 투자했습니다. MultiOmic Health는 정밀 치료제 발견 플랫폼을 구축하기 위해 620만 달러의 자금 조달을 완료했습니다.

시장 관계자가 혁신적인 제품 및 서비스 개발에 중점을 두고 있는 것도 시장 수요를 전진시키는 중요한 요인입니다. Via Scientific Inc.는 멀티오믹스 연구 중 복잡한 데이터와 분석 작업의 자동화를 지원하는 멀티오믹스 액셀러레이터 플랫폼, 주조를 발표했습니다.

멀티오믹스 시장 보고서 하이라이트

제품 및 서비스 부문에 근거하면, 2024년 시장 수익 점유율은 최대였습니다.
유형별로는 벌크 멀티오믹스 부문이 2024년 최대 시장 수익 점유율을 차지했습니다.
플랫폼별로는 유전체학가 2024년의 매출 점유율 40.63%로 시장을 독점했습니다.
용도별로는 암분야가 2024년 최대 시장수익 점유율을 차지했습니다.
최종 용도별로는 학술기관 및 연구기관 부문이 2024년에 가장 큰 시장수익 점유율을 차지했습니다.
북미는 2024년에 48.76%의 수익 점유율로 세계 시장을 독점했지만, 이는 이 지역에 주요 시장 기업이 존재하기 때문입니다.

지역 대시보드
시장 규모와 예측 및 동향 분석, 2021-2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제10장 경쟁 구도

참가 기업
전략 매핑
기업시장 포지셔닝 분석, 2024년
참가 기업의 개요
- BD
- Thermo Fisher Scientific Inc.
- Illumina, Inc
- Danaher
- PerkinElmer Inc.
- Shimadzu Corporation
- Bruker
- QIAGEN
- Agilent Technologies, Inc.
- BGI

SHW

영문 목차

영문목차

Multiomics Market Growth & Trends:

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Type
- 1.2.3. Platform
- 1.2.4. Application
- 1.2.5. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

4.1. Segment Dashboard
4.2. Global Multiomics Market Product & Service Movement Analysis
4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Product
- 4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Instruments
  - 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Consumables
  - 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Software
  - 4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
- 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

5.1. Segment Dashboard
5.2. Global Multiomics Market Type Movement Analysis
5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Single-cell Multiomics
- 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Bulk Multiomics
- 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

6.1. Segment Dashboard
6.2. Global Multiomics Market Platform Movement Analysis
6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
6.4. Genomics
- 6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Transcriptomics
- 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Proteomics
- 6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Metabolomics
- 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Integrated Omics Platforms
- 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

7.1. Segment Dashboard
7.2. Global Multiomics Market Application Movement Analysis
7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Cell Biology
- 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Oncology
- 7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Neurology
- 7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Immunology
- 7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

8.1. Segment Dashboard
8.2. Global Multiomics Market End-use Movement Analysis
8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
8.4. Academic and Research Institutes
- 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Pharmaceutical & Biotechnology Companies
- 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Others
- 8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
- 9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Europe
- 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Framework
  - 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Framework
  - 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Australia
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. South Korea
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. MEA
- 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Framework
  - 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Framework
  - 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Participant's Overview
- 10.4.1. BD
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. Thermo Fisher Scientific Inc.
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. Illumina, Inc
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. Danaher
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. PerkinElmer Inc.
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. Shimadzu Corporation
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. Bruker
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. QIAGEN
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Agilent Technologies, Inc.
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. BGI
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Strategic Initiatives

한글목차

멀티오믹스 시장의 성장과 동향 :

멀티오믹스 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

제4장 멀티오믹스 시장 : 제품 및 서비스의 비즈니스 분석

제5장 멀티오믹스 시장 : 유형의 비즈니스 분석

제6장 멀티오믹스 시장 : 플랫폼의 비즈니스 분석

제7장 멀티오믹스 시장 : 용도의 비즈니스 분석

제8장 멀티오믹스 시장 : 최종 용도의 비즈니스 분석

제9장 멀티오믹스 시장 : 지역 비즈니스 분석